ML14070A236
| ML14070A236 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies |
| Issue date: | 03/05/2014 |
| From: | SHINE Medical Technologies |
| To: | Office of Nuclear Reactor Regulation |
| References | |
| SMT-2014-006 | |
| Download: ML14070A236 (58) | |
Text
ENCLOSURE2 SHINE MEDICAL TECHNOLOGIES, INC.
SHINE MEDICAL TECHNOLOGIES, INC. PROPOSED FACILITY DESIGN CHANGES AND IMPACT ON THE PSAR REQUEST TO WITHHOLD INFORMATION FROM PUBLIC DISCLOSURE SHINE MEETING SLIDES PUBLIC VERSION 54 pages follow
SSHINE Medical Technologies SHINE Facility Design Changes and Impact on the PSAR March 19, 2014
Nine design changes are being proposed for the SHINE facility. The basis for these changes are to:
Enhance Safety Optimize use of resources Improve constructability Facilitate efficient operations and maintenance SHINE 2
edical Technologies
The changes are:
- 1. Eliminate crane in supercell area
- 2. Reduce production building height
- 3. Reduce production building roof thickness
- 4. Relocate noble gas storage
- 5. Eliminate crane in RPF tank farm area
- 6. Optimize equipment layout in the IF area
- 7. Resize IF crane and improve crane supports
- 8. Relocate bulk chemical storage
- 9. Relocate normal switchgear SHINE'T edicol Technologies
Safety enhancements:
Industrial safety
- Reduces the potential for lifting mishaps Improves ability to easily monitor and adjust crane rail alignment Reduces potential chemicals hazards in production facility Reduces high elevation work activities Simplifies cable runs Improves reliability Improves maintenance efficiency Radiation safety Improves worker safety (ALARA)
Provides additional radiation shielding Nuclear safety Improves defense-in-depth of electrical equipment Reduces combustible loading Reduces production facility profile SSHINE Medical Technologies
Requires updates to:
Structural analysis Chemical release analysis Noble gas accident analysis Aircraft impact analysis Accident dose analysis Safety analysis limits will be met or the design change will not be made The analyses will be updated and the PSAR will be revised and provided to the NRC SHINE Medical Technologies
Eliminate Crane in Supercell Area
Description:
Eliminate 40-ton overhead bridge crane system (0C-0003) in the supercell area of the RPF and use dedicated jib cranes for the supercells
" The crane provides coverage over the receipt area and supercells and is seismic Il/I (no change; jib cranes perform the same function)
" The overhead crane has no safety function fl SHINE dical Technologies
Elmnt Crn in Suecl Are
" Impact on SSC
" Analyzed offsite dose consequences: no change
" Structural analysis revision needed; structural loading is decreased by removing crane live loads and load combinations, and structural capacity (margin) is increased
- m No impact on other SSC
" Safety enhancement: Enhances worker and plant safety by reducing the potential for lifting mishaps over other operating equipment. The jib cranes will have restricted movement to reduce risk to other plant equipment.
Workers will have full visibility of the lift and the load path.
- SHINE" mdical Technologies
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
Proprietary Information Security-Related Information w1,SHINE" Mdical Technologies 8
[Proprietary Information - Withheld from Public Disclosure Under 10 CER 2.390(a)(4)]
Elmnt Crn n*uecl Are MW0 Proprietary Information Security-Related Information SmSHINE edical Technologies 9
eSHINETe edciTechnologies 10
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a) (4)]
ElimnateCran in uperellAre
- a.
.1 0
wn Proprietary Information Security-Related Information ISHINE dical Technologies 11
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
Elmnt Crn inSpecl Area Proprietary Information Security-Related Information IN, SHINE dicol Technologies 12
- SHINE' Medical Technologies 13
Reuc PoutnBuiligHih
Description:
The production facility height will be reduced by approximately six feet
" The production building protects and houses plant equipment, including safety significant SSC, and provides confinement (no change)
H SHINE medical Technologies
" Impact on SSC
" Aircraft impact analysis revision needed; reanalysis expected to accommodate aircraft impact loads
" Structural analysis revision needed; reanalysis expected to accommodate seismic loads
" Accident analysis revision needed
" Analyzed consequences will meet dose limits
" No impact on other SSC
- Safety enhancement: Enhances construction worker safety by reducing high elevation work activities; reduces production facility profile
, SHINE 15 medical Technologies
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
Proprietary Information Security-Related Information 1w1ýSHINE' mdical Technologies 16
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
Proprietary Information Security-Related Information
- SHINE' Medical Technologies 17
[qer~ijritv-Reklted Infnrmation-Withheld Under 10 CFR 2.3901
Description:
The production facility roof thickness is reduced from [ Security-Related Information ] in most areas
" The production building protects and houses plant equipment, including safety significant SSC, and provides confinement (no change) wjýHINE`1 w4 Mdical Technologies
I Impact on SSC
" Analyzed offsite dose consequences: no change
" Aircraft impact analysis revision needed; reanalysis expected to accommodate aircraft impact loads
" Structural analysis revision needed; reanalysis expected to accommodate seismic loads
" No impact on other SSC
- Safety enhancement: Enhances construction worker safety by reducing high elevation work activities SjSHINE 19 Medical Technologies
Membrane roofing Rigid insulation Hsstin& vontileting and air conditioning duct Utility ducts:
telephone and power
- SHINE 20 Medical Technologies
Description:
Relocate the noble gas storage tanks from the above grade area to new underground vault section in the RPF
- The noble gas cell contains contents of the noble gas tanks in the event of a release from one or more tanks (no change)
" The noble gas cell provides confinement and biological shielding (no change) all 21 fSHINE 4
Medical Technologies
- Impact on SSC
" Structural analysis revision needed
" Noble gas accident analysis revision needed
- Analyzed consequences will meet dose limits
- No impact on other SSC
- Safety enhancement: Improves worker safety (ALARA)
- SHINE"2 Medical Technologies
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
Proprietary Information Security-Related Information S HHINE medical Technologies 23
[ProDrietarv Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(,
Proprietary Information Security-Related Information SSHINE dical Technologies 24
[Prnnript~qrv Infnrmqtinn - Withh~id f rom Pi jh~irn iqrcdoqi irI Infrk-r 10 nFR 290h(~
Proprietary Information Security-Related Information jSHINE dical Technologies 25
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
Relocate Noble Gas Storage W-zgQ 71 Proprietary Information Security-Related Information gSHINE dical Technologies 26
Elmnt Crn inRFTakFr Area
Description:
Eliminate the overhead bridge crane (OC-0002) in the RPF tank farm area and replace with a mobile crane
" The RPF tank farm area crane provides coverage over the tank farm area of the RPF and is seismic 1/1 (no change; mobile crane performs the same function)
" The RPF tank farm area crane has no safety function S2HINE7 Medicol Technologies
" Impact on SSC
" Analyzed offsite dose consequences: no change
" Structural analysis revision needed; structural loading is decreased by removing crane live loads and load combinations, and structural capacity (margin) is increased
" No impact on other SSC
" Safety enhancement: Improves worker safety during construction.
SSHINE" medical Technologies
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
Elimnat Crne n
R Tnk armArea 0
0 0
0 Proprietary Information Security-Related Information S
SHINE Medical Technologies 29
[Proprietary I nformation - Withheld from Public Disclosure Under 10 CER 2.390(a)(4)]
Eliminte Crne.in....Tnk Fam.Ar.
Proprietary Information Security-Related Information Thn SHINE" 1h Mdical Technologies 30
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
Eliminater Crn-nRFTn amAe Proprietary Information Security-Related Information iJ4 al SHINE"e MdclTechnologies 31
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
Proprietary Information Security-Related Information w1 SHINE" Mdical Technologies 32
,SHINE' Medical Technologies
Description:
Equipment and systems in the IF area are rearranged. The rearrangement:
" Groups TSV off-gas systems
" Groups primary cooling systems
" Adds a neutron driver service area
" Eliminates IF piping trench system
- The IF structure supports and allows access to equipment (no change)
" The IF structure provides shielding, confinement, and seismic support (no change)
JSHINE medical Technologies
0.imz Eqimn Laou in the IF Area
" Impact on SSC
- Analyzed offsite dose consequences: no change
- Structural analysis revision needed; structural loads are reduced
- No impact on other SSC
" Safety enhancement: Improves worker and plant safety by simplifying design; improves ALARA fl ISHINE 3
mdical Technologies
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
Proprietary Information Security-Related Information T1, SHINE" Medical Technologies 36
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
Proprietary Information Security-Related Information
- SHINE" dicol Technologies 37
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
0.imz Eqimn Laou in th IF Area Proprietary Information Security-Related Information
- SHINE' dical Technologies 38
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
Proprietary Information Security-Related Information ThnHINEs Mdical Technologies 39
Resize IF Crane and Improve Crane
Su-pp rts
Description:
" Reduced lifting requirements allowing reduction in crane capacity from 75 to 30 tons
- Replace the present bridge crane embedded support rails with embedded wall plates that have welded crane rail supports
" The IF crane services equipment in the IF area, and is designed to be seismic Il/I (no change)
" The IF crane has no safety function SSHINE Medical Technologies
" Impact on SSC
- Analyzed offsite dose consequences: no change
" Structural analysis revision needed; structural loading is decreased by decreasing crane live loads and load combinations, and structural capacity (margin) is increased; also improved crane rail support
- m No impact on other SSC
" Safety enhancement: Allows for ability to easily monitor and adjust crane rail alignment during maintenance periods
- ISHINE 41 Medical Technologies
IFBuilding SHINE 42 Medical Technologies
Relocate Chemical Storage WQý
Description:
Relocate chemical storage to a building outside of the production facility
" Chemical storage provides safe storage and containment of chemicals (no change)
" Chemical storage contains releases or spills (no change)
SSHINET Medical Technologies
Relocate Chemical Storage
- Impact on SSC
- Revision of chemical accident analysis needed
- Analyzed consequences will meet limits
- No impact on other SSC
- Safety enhancement: Reducing chemical hazards along the egress route
,NSHINE" medical Technologies
[Prnnric~t~nn I nfnrmrntinn-With h~indfrnmn Piihli n fi-Qr~inqirP Llnr1pr in r.FR 29 q0(;,)w1 Proprietary Information Security-Related Information j SHINE Medicol Technologies 45
rPronrietarv Information-Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)1 Proprietary Information Security-Related Information dical Technologies 46
[Prnnriiptnrv I nfnrmqitinn - Withh~id frnm Pifihfir~ ni~qronijrP 1nripr 10 (FR P~0~4f Proprietary Information Security-Related Information
- SHINE dicol Technologies 47
Description:
Relocation of non safety-related switchgear from non-seismic area to seismic area
- The switchgear supports normal electrical distribution (no change)
- The switchgear has no safety function
- SHINE" 4
B lMedicoI Technologies
- Impact on SSC
" Analyzed offsite dose consequences: no change
" Structural analysis revision needed; adds minimal additional loads to the walls
- No impact to other SSC
- Safety enhancement: Improves defense-in-depth of non safety-related switchgear by relocating to seismic area; provides more protection from external events; reduces combustible loading; simplifies cable runs; improves reliability SHINE Medicol Technologies
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
Proprietary Information Security-Related Information l SHINEs dclTechnologies 50
[Proprietary Information - Withheld from Public Disclosure Under 10 CER 2.390(a)(4)]
Relocat Noma 0
- che Proprietary Information Security-Related Information NSHINE dical Technologies 51
[Proprietary Information - Withheld from Public Disclosure Under 10 CFR 2.390(a)(4)]
Relocate Normal Switchgear
--7= 77.777"
-5 Ov-Proprietary Information Security-Related Information
- ISHINE medical Technologies 52
[Security-Related Information - Withheld Under 10 CFR 2.390]
Reoae NomlSicga Security-Related Information fl SHINE Mdical Technologies 53
These proposed changes to the facility will improve industrial, nuclear, and radiation safety.
Analyses will be updated as a result of the improvements and the applicable limits will be met or the change will not be implemented.
The PSAR will be updated and provided to the NRC.
SSHINE" Medical Technologies
ENCLOSURE 3 SHINE MEDICAL TECHNOLOGIES, INC.
SHINE MEDICAL TECHNOLOGIES, INC. PROPOSED FACILITY DESIGN CHANGES AND IMPACT ON THE PSAR REQUEST TO WITHHOLD INFORMATION FROM PUBLIC DISCLOSURE AFFIDAVIT OF RICHARD VANN BYNUM 2 pages follow
)ss.
COUNTY OF DANE I, Richard Vann Bynum, Chief Operating Officer of SHINE Medical Technologies, Inc. (SHINE),
do hereby affirm and state:
1.
I am authorized to execute this affidavit on behalf of SHINE. I am authorized to review information submitted to or discussed with the Nuclear Regulatory Commission (NRC) and apply for the withholding of information from public disclosure. The purpose of this affidavit is to provide the information required by 10 CFR 2.390(b) in support of SHINE's request for proprietary treatment of certain confidential commercial information submitted in the SHINE response to the NRC staff's environmental requests for additional information. SHINE requests that the confidential information contained in Enclosure 1 be withheld from public disclosure.
- 2.
I have knowledge of the criteria used by SHINE in designating information as sensitive, proprietary, or confidential.
- 3.
Pursuant to the provisions of paragraph (a)(4) of 10 CFR 2.390, the following is furnished for NRC consideration in determining whether the information sought to be withheld from public disclosure should be withheld.
- a. The information sought to be withheld from public disclosure contained in of SMT-2014-006 is owned by SHINE, its affiliates or third parties to whom SHINE has an obligation to maintain its confidentiality. This information is and has been held in confidence by SHINE.
- b. The information sought to be protected in Enclosure 1 is not available to the public to the best of my knowledge and belief.
1
- c. The information contained in Enclosure 1 is of the type that is customarily held in confidence by SHINE, and there is a rational basis for doing so. The information that SHINE is requesting to be withheld from public disclosure includes trade secret, commercial information or information that is subject to export controls. SHINE limits access to these elements to those individuals with a "need to know," and subject those individuals to maintaining confidentiality.
- d. The proprietary information sought to be withheld from public disclosure in includes, but is not limited to: structural configuration, primary and supporting systems of the medical isotope facility, process and system locations, and process details. This would include information regarding the types, quantities, and locations of materials stored on site as would be referenced in facility configuration drawings. Public disclosure of the information in Enclosure 1 would create substantial harm to SHINE because it would reveal trade secrets owned by SHINE, its affiliates or third parties to whom SHINE has an obligation to maintain its confidentiality.
- e. The information contained in Enclosure 1 of letter SMT-2014-006 is transmitted to the NRC in confidence and under the provisions of 10 CFR 2.390; it is to be received in confidence by the NRC. The information is properly marked.
I declare under the penalty of perjury that the foregoing is true and correct.
Executed on March 5, 2014.
Richard Vann ffynum, Ph.D.
COO - SHINE Medical Technologies, Inc.
2